Compared to conventional cancer treatment, combination therapy based on well-designed nanoscale platforms may offer an opportunity to eliminate tumors and reduce recurrence and metastasis. In this study, we prepared multifunctional microspheres loading (131)I-labeled hollow copper sulfide nanoparticles and paclitaxel ((131)I-HCuSNPs-MS-PTX) for imaging and therapeutics of W256/B breast tumors in rats. (18)F-fluordeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) imaging detected that the expansion of the tumor volume was delayed (P<0.05) following intra-tumoral (i.t.) injection with (131)I-HCuSNPs-MS-PTX plus near-infrared (NIR) irradiation. The immunohistochemical analysis further confirmed the anti-tumor effect. The single photon emission computed tomography (SPECT)/photoacoustic imaging mediated by (131)I-HCuSNPs-MS-PTX demonstrated that microspheres were mainly distributed in the tumors with a relatively low distribution in other organs. Our results revealed that (131)I-HCuSNPs-MS-PTX offered combined photothermal, chemo- and radio-therapies, eliminating tumors at a relatively low dose, as well as allowing SPECT/CT and photoacoustic imaging monitoring of distribution of the injected agents non-invasively. The copper sulfide-loaded microspheres, (131)I-HCuSNPs-MS-PTX, can serve as a versatile theranostic agent in an orthotopic breast cancer model.
The combined therapeutic effects of (131)iodine-labeled multifunctional copper sulfide-loaded microspheres in treating breast cancer.
碘标记的多功能硫化铜负载微球在治疗乳腺癌中的联合治疗效果
阅读:6
作者:Liu Qiufang, Qian Yuyi, Li Panli, Zhang Sihang, Wang Zerong, Liu Jianjun, Sun Xiaoguang, Fulham Michael, Feng Dagan, Chen Zhigang, Song Shaoli, Lu Wei, Huang Gang
| 期刊: | Acta Pharmaceutica Sinica B | 影响因子: | 14.600 |
| 时间: | 2018 | 起止号: | 2018 May;8(3):371-380 |
| doi: | 10.1016/j.apsb.2018.04.001 | 研究方向: | 肿瘤 |
| 疾病类型: | 乳腺癌 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
